Medications

U.S. FDA Approves New Indication for Merck’s Prevymis (letermovir) for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Adult Kidney Transplant Recipients

RAHWAY, N.J.–(BUSINESS WIRE) June 6, 2023 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada,

Read more